Wagner-nelson Method
Wagner-nelson Method - Related Videos
01:24
One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation
0 Views •
2025
This lesson introduces two critical methods in pharmacokinetics, the Wagner-Nelson and Loo-Riegelman methods, used for estimating the absorption rate constant (ka) for drugs administered via non-intravenous routes. The Wagner-Nelson method relates ka to the plasma concentration derived from the slope of a semilog percent unabsorbed time plot. However, it is limited to drugs with one-compartment kinetics and can be impacted by factors like gastrointestinal motility or enzymatic degradation. On...
08:08
Creating a Winogradsky Column: A Method to Enrich the Microbial Species in a Sediment Sample
0 Views •
2023
Source: Elizabeth Suter1, Christopher Corbo1, Jonathan Blaize1 1 Department of Biological Sciences, Wagner College, 1 Campus Road, Staten Island NY, 10301 The Winogradsky column is a miniature, enclosed ecosystem used for enriching sediment microbial communities, especially those involved in sulfur cycling. The column was first used by Sergei Winogradsky in the 1880s and has since been applied in the study of many diverse microorganisms involved in biogeochemistry, such as photosynthesizers,...
13:30
A New Screening Method for the Directed Evolution of Thermostable Bacteriolytic Enzymes
0 Views •
Cited by 36 •
2012
A novel directed evolution method specific to the field of thermostability engineering was developed and consequently validated for bacteriolytic enzymes. After only one round of random mutagenesis, an evolved bacteriolytic enzyme, PlyC 29C3, displayed greater than twice the residual activity when compared to the wild-type protein after elevated temperature incubation.
09:32
Procedure and Key Optimization Strategies for an Automated Capillary Electrophoretic-based Immunoassay Method
0 Views •
Cited by 15 •
2017
A capillary-based immunoassay using a commercial platform to measure target proteins from total protein preparations is demonstrated. In addition, assay parameters of exposure time, protein concentration, and antibody dilution are optimized for a cell culture model system.
07:56
Filtration Isolation of Nucleic Acids: A Simple and Rapid DNA Extraction Method
0 Views •
Cited by 6 •
2016
We describe here a simple and rapid paper-based DNA extraction method of HIV proviral DNA from whole blood detected by quantitative PCR. This protocol can be extended for use in detecting other genetic markers or using alternative amplification methods.
FAQs
The calculation treats the observed plasma profile as the net result of two concurrent processes: drug entering the body after oral dosing and drug being removed by elimination. By combining the concentration-time area accumulated up to a given time with the current concentration and the elimination rate constant, it estimates the input attributable to absorption. This enables absorption to be followed over time.
The elimination rate constant provides the correction for drug loss during the absorption period. A larger or smaller value changes how much of the measured concentration-time profile is assigned to elimination rather than ongoing input. Because the calculation depends on this parameter, an appropriate one-compartment, first-order elimination model is central to obtaining a meaningful absorbed-fraction estimate.
Interpretation typically assumes one-compartment behavior and first-order elimination. Under these conditions, plasma concentrations can be used to distinguish drug removal from continuing absorption after oral administration. Changes in dosage form or administration conditions may alter the observed profile, so the estimated absorption pattern should be interpreted in relation to the specific formulation and dosing conditions studied.
An absorption estimate and systemic exposure answer different questions. The Wagner-Nelson Method uses the plasma concentration-time profile to examine when drug input occurs, whereas the overall area under that profile reflects systemic drug exposure. Considering both helps investigators distinguish altered absorption behavior from changes in total exposure when comparing formulations or administration conditions.
The workflow begins with plasma concentration measurements collected across time after oral administration. Investigators then use the observed concentration-time profile, the elimination rate constant, and areas under the curve to calculate the fraction absorbed at successive times. The resulting time course can be examined for absorption behavior and compared across dosage forms or administration conditions.
Researchers can apply the same analysis to concentration-time data from different dosage forms and compare the resulting absorption profiles. Differences may indicate that a formulation changes the rate or pattern of drug absorption, while the associated areas under the curves provide information about systemic exposure. This supports assessment of formulation performance in clinical pharmacokinetic studies.
Bioequivalence evaluations may require more than comparing overall exposure because formulations can differ in how quickly drug absorption occurs. The method provides a time-based estimate of absorbed fraction from plasma data, allowing investigators to examine absorption rates alongside concentration-time exposure. This can help characterize whether dosage-form differences influence systemic drug input.
In clinical research, the method connects measured plasma concentrations with the timing of drug absorption after oral dosing. Investigators can use the resulting estimates to characterize absorption, evaluate dosage-form performance, and examine the effects of administration conditions. Its value lies in separating drug input from elimination within the stated one-compartment, first-order framework.